Norbert Frickhofen

Malignant Tumors Occurring after Treatment of Aplastic Anemia

Gèrard Socié, M. Henry‐Amar, Andrea Bacigalupo et al. · New England Journal of Medicine · 1993 · 464 citations · Full text

Pure Red-Cell Aplasia of 10 Years' Duration Due to Persistent Parvovirus B19 Infection and Its Cure with Immunoglobulin Therapy

Gary J. Kurtzman, Norbert Frickhofen, Janice Kimball et al. · New England Journal of Medicine · 1989 · 433 citations

Vaccination, Viral Persistence, Bone Marrow Failure +15

Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation

Norbert Schmitz, Andrea Bacigalupo, Dirk Hasenclever et al. · Bone Marrow Transplantation · 1998 · 264 citations

Cell Therapy, Transplantation, Marrow Transplantation +8

Late clonal diseases of treated aplastic anemia

Gérard Socié, Stephen J. Rosenfeld, Norbert Frickhofen et al. · Seminars in Hematology · 2000 · 166 citations

Bone Marrow Failure, Hematology, Pathology +3

6-Thioguanine, Cytarabine, and Daunorubicin (TAD) and High-Dose Cytarabine and Mitoxantrone (HAM) for Induction, TAD for Consolidation, and Either Prolonged Maintenance by Reduced Monthly TAD or TAD-HAM-TAD and One Course of Intensive Consolidation by Sequential HAM in Adult Patients at All Ages With De Novo Acute Myeloid Leukemia (AML): A Randomized Trial of the German AML Cooperative Group

Thomas Büchner, Wolfgang Hiddemann, Wolfgang E. Berdel et al. · Journal of Clinical Oncology · 2003 · 163 citations